enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. This Chronic Skin Condition Is A Common Cause Of Dark ... - AOL

   www.aol.com/lifestyle/chronic-skin-condition...

   In short, melasma is a chronic skin condition that appears as darkened areas on the face due to an overproduction of melanin, says Gina Charles, MO, a family physician specializing in skincare. It ...

3. Over Your Melasma? Here's *Exactly* How to Get Rid of It - AOL

   www.aol.com/over-melasma-heres-exactly-rid...

   How to choose the best melasma treatment. First off, seeing a derm is the best thing you can do, "because people often misdiagnose themselves," says Dr. Westbay. In the meantime, be extra-careful ...

4. 11 dermatologist-approved melasma treatments of 2023

   www.aol.com/news/11-dermatologist-approved...

   Azelaic acid, which this product is formulated with, is a great over-the-counter (and pregnancy-safe) alternative to prescription hydroquinone, an old-school treatment for melasma. “[Azelaic ...

5. Skin whitening - Wikipedia

   en.wikipedia.org/wiki/Skin_whitening

   One 2017 review found tentative evidence of benefit of tranexamic acid in melasma. [13] Another 2017 review found that evidence to support its use was insufficient. [14] Azelaic acid may be a second-line option for melasma. [15] A number of types of laser treatments have been used in melasma with some evidence of benefit. [16]

6. Melasma - Wikipedia

   en.wikipedia.org/wiki/Melasma

   More recently, a systematic review found that oral medications also have a role in melasma treatment, and have been shown to be efficacious with a minimal number and severity of adverse events. Oral medications and dietary supplements employed in the treatment of melasma include tranexamic acid , Polypodium leucotomos extract, beta‐carotenoid ...

7. Patanjali Ayurved - Wikipedia

   en.wikipedia.org/wiki/Patanjali_Ayurved

   Patanjali Food and Herbal Park in Haridwar is the company's main production facility. With a production capacity of ₹ 35,000 crore (equivalent to ₹ 470 billion or US$5.6 billion in 2023), it is expanding to a capacity of ₹ 60,000 crore (equivalent to ₹ 860 billion or US$10 billion in 2023) through new production units in Noida, Nagpur, and Indore.